What is multiple myeloma?

Last medical review:

Multiple myeloma is a cancer that starts in plasma cells. Plasma cells are a type of white blood cell that makes antibodies (also called immunoglobulins) to help the body fight infection.

Plasma cells are found mainly in the bone marrow but are also in some other tissues and organs. Bone marrow is the soft, spongy tissue inside most bones where different types of blood cells are made.

Plasma cells in the bone marrow sometimes change and no longer grow or behave normally. These abnormal plasma cells (called myeloma cells) begin to divide uncontrollably and make more myeloma cells. Over time, the myeloma cells crowd out normal blood cells so they can't do their jobs. The myeloma cells can also cause bones to become weak. When the bones are weakened or damaged, 2 types of bone cells don't work together the way they usually do. Osteoblasts make bone and osteoclasts break down bone. Myeloma cells stimulate the osteoclasts to break down bone at a much quicker rate than normal.

Diagram of plasma cell development
Diagram of plasma cell development

Changes to the plasma cells can cause a precancerous condition called monoclonal gammopathy of undetermined significance (MGUS). Precancerous means that the cells are not yet cancer, but there is a higher chance they will become cancer.

In some cases, MGUS can progress to a plasma cell cancer. The most common type of plasma cell cancer is multiple myeloma. Other plasma cell cancers include solitary plasmacytoma and extramedullary plasmacytoma.

Plasma cell cancers can develop when there is a buildup of many myeloma cells in the bone marrow. Myeloma cells can form tumours in the bones (called plasmacytomas).

  • Solitary plasmacytoma is when there is only one tumour in a bone.
  • Multiple myeloma is when there are many tumours in the bones.
  • Extramedullary plasmacytoma is when myeloma cells form tumours in soft tissues outside of the bones.

There are other conditions related to multiple myeloma including:

Expert review and references

  • Guido Lancman, MD, MSc
  • American Cancer Society. What is Multiple Myeloma?. 2018. https://www.cancer.org/.
  • Berenson JR. Overview of plasma cell disorders. Merck Manual Consumer Version. Kenilworth, NJ: Merck & Co, Inc; 2023. https://www.merckmanuals.com/en-ca/home.
  • PDQ® Adult Treatment Editorial Board. Plasma Cell Neoplasms (including Multiple Myeloma) (PDQ®) – Patient Version. Bethesda, MD: National Cancer Institute; 2023. https://www.cancer.gov/.
  • Rajkumar V, Kumar S. Plasma Cell Neoplasms. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Philadelphia, PA: Wolters Kluwer; 2023: Kindle version, [chapter 74], https://read.amazon.ca/?asin=B0BG3DPT4Q&language=en-CA.

The plasma cells

Multiple myeloma is a cancer of the plasma cells, a type of white blood cell.

Types of multiple myeloma

Multiple myeloma is the most common type of plasma cell cancer. Other types include solitary plasmacytoma of the bone and extramedullary plasmacytoma.

Monoclonal gammopathy of undetermined significance

Monoclonal gammopathy of undetermined significance (MGUS) is a precancerous condition and the most common plasma cell disorder. Over time, MGUS may develop into multiple myeloma.

Conditions related to multiple myeloma

There are conditions related to multiple myeloma including osteosclerotic myeloma, Waldenstrom macroglobulinemia and other related conditions.

Your trusted source for accurate cancer information

With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society